¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"concentration effect"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • antioxidant effect
    Ç×»êÈ­È¿°ú
  • antitussive effect
    Ç×±âħȿ°ú, ÁøÇØÈ¿°ú
  • additive effect
    ºÎ°¡È¿°ú
  • adverse effect
    À¯ÇØÈ¿°ú
  • beam hardening effect
    ºö°æÈ­È¿°ú
  • back-pressure effect
    ÈĹæ¾Ð·ÂÈ¿°ú
  • biologic effect
    »ý¹°ÇÐÀûÈ¿°ú
  • bacteriostatic effect
    Á¤±ÕÈ¿°ú
  • blow back effect
    µÞ¹Ù¶÷È¿°ú, ÈÄdzȿ°ú
  • cohort effect
    ÄÚȣƮȿ°ú
  • combined effect
    º´¿ëÈ¿°ú
  • cumulative effect
    ´©ÀûÈ¿°ú, ÃàÀûÈ¿°ú
  • curative effect
    Ä¡·áÈ¿°ú
  • cytopathic effect
    ¼¼Æ÷º´º¯È¿°ú
  • carrier effect
    ¿î¹Ýüȿ°ú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • additive effect
    ºÎ°¡È¿°ú, »ó°¡È¿°ú
  • adverse effect
    ¿ªÈ¿°ú, À¯ÇØÈ¿°ú
  • antagonistic effect
    ¸Â¹öÆÀÈ¿°ú, ´ëÇ×È¿°ú
  • anticoagulant effect
    Ç×ÀÀ°íÈ¿°ú
  • antioxidant effect
    Ç×»êÈ­È¿°ú
  • antitoxemic effect
    Ç×µ¶Ç÷ÁõÈ¿°ú
  • antitussive effect
    Ç×±âħȿ°ú, ÁøÇØÈ¿°ú
  • back-pressure effect
    ÈĹæ¾Ð·ÂÈ¿°ú
  • bacteriostatic effect
    Á¤±ÕÈ¿°ú
  • beam hardening effect
    ºö°æÈ­È¿°ú
  • binaural hearing effect
    µÎ±Íµè±âÈ¿°ú
  • biologic effect
    »ý¹°ÇÐÀûÈ¿°ú
  • blow back effect
    µÞ¹Ù¶÷È¿°ú, ÈÄdzȿ°ú
  • bridle effect
    °í»ßÈ¿°ú, Á¦¾îÈ¿°ú
  • carrier effect
    ¿î¹Ýüȿ°ú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • RF antennae effect
    °íÁÖÆÄ ¾ÈÅ׳ª È¿°ú
  • Stiles-Crawford effect
    ½ºÅ¸ÀϽº-Å©·ÎÆ÷µåÈ¿°ú
  • T1 shortening effect
    T1 ´ÜÃà È¿°ú
  • T2 shortening effect
    T2 ´ÜÃà È¿°ú
  • Tyndall effect
    ƾ´ÞÈ¿°ú
  • additive effect
    ºÎ°¡È¿°ú
  • additive effect
    »ó°¡È¿°ú (ßÓÊ¥üùÍý)
  • adverse effect
    ¿ªÈ¿°ú(æ½üùÍý).¾à¸®À¯ÇØÈ¿°ú.
  • adverse effect
    ¿ªÈ¿°ú, À¯ÇØÈ¿°ú
  • air barrier effect
    °ø±â¸·È¿°ú(ÍöѨدüùÍý).
  • air gap effect
    °ø±â °£°Ý È¿°ú
  • allogeneic effect
    µ¿Á¾ÀÌÇüÈ¿°ú
  • analgesic effect
    ÁøÅëÈ¿°ú.
  • antagonistic effect
    ±æÇ×È¿°ú
  • anticoagulant effect
    Ç×ÀÀ°íÈ¿°ú.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • mchc=nmean corpuscular hemoglobin concentration
    Æò±ÕÀûÇ÷±¸Ç÷»ö¼Ò³óµµ(¡­ÒØÓø)
  • mean cell hemoglobin concentration
    Æò±ÕÀûÇ÷±¸Ç÷»ö¼Ò³óµµ
  • mean corpuscular hemoglobin concentration
    Æò±ÕÀûÇ÷±¸Ç÷»ö¼Ò³óµµ(øÁгîåúìϹúìßäáÈÒØÓø)
  • mean corpuscular hemoglobin concentration =MCHC
    Æò±ÕÀûÇ÷±¸Ç÷»ö¼Ò³óµµ(Ì°Ë»ËøÌ´Ë´Ì´Ë×ËÛËÀ̬).
  • mean corpuscular hemoglobin concentration =MCHC
    Æò±ÕÀûÇ÷±¸Ç÷»ö¼Ò³óµµ(øÁгîåúìϹúìßäáÈÒØöô).
  • minimal bactericidal concentration (MBC)
    »ì±ÕÃÖ¼Ò³óµµ
  • minimal effective analgesic concentration
    ÃÖ¼ÒÈ¿°úÀûÁøÅë³óµµ
  • minimal inhibitory concentration
    ÃÖÀú¹ßÀ°ÀúÁö³óµµ(õÌî¸Û¡ëÀðæò­ÒØöô).
  • minimum alveolar concentration
    ÃÖ¼ÒÆóÆ÷³»³óµµ.
  • minimum anesthetic concentration
    ÃÖ¼Ò¸¶Ãë³óµµ(õÌá³Ø«ö­ÒØöô).
  • minimum bactericidal concentration
    ÃÖ¼Ò»ì±Õ³óµµ
  • minimum bactericidal concentration(MBC)
  • minimum blocking concentration
    ÃÖ¼ÒÂ÷´Ü³óµµ
  • minimum inhibitory concentration
    ÃÖ¼Ò¹ßÀ°ÀúÁö³óµµ(õÌá³Û¡ëÀîÁò­ÒØöô).
  • minimum inhibitory concentration
    ÃÖ¼Ò¾ïÁ¦³óµµ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Coulomb effect
    "Äí·Õ È¿°ú(üùÍý),(ÔÒ) ion-ion interaction"
  • Crabtree effect
    Å©·¡ºêÆ®¸® È¿°ú(üùÍý)
  • dispersion effect
    "ºÐ»ê È¿°ú(ÝÂߤüùÍý), (ÔÒ) dispersion forces"
  • Dorn effect
    "µ· È¿°ú(üùÍý), (ÔÒ) sedimentation potential"
  • drag effect
    ²ø¸² È¿°ú(üùÍý) (ÔÒ) solvent drag
  • dual-effect mutant
    ÀÌÁßÈ¿°ú º¯ÀÌü(ì£ñìüùÍýܨì¶ô÷)
  • electrochromic effect
    Àü±âº¯»ö È¿°ú(ï³Ñ¨Ü¨ßäüùÍý)
  • electrophoretic effect
    Àü±â¿µµ¿ È¿°ú(ï³Ñ¨ç¶ÔÑüùÍý)
  • electroviscous effect
    Àü±âÁ¡¼º È¿°ú(ï³Ñ¨ïÄàõüùÍý)
  • enhancement effect
    Áõ°­ È¿°ú (ñòË­üùÍý)
  • extrinsic Cotton effect
    ¿ÜÀμº(èâì×àõ) ÄÚÆ° È¿°ú(üùÍý)
  • Faraday effect
    ÆÐ·¯µ¥ÀÌ È¿°ú(üùÍý)
  • field effect
    ÀåÈ¿°ú(íÞüùÍý)
  • founder effect
    ½ÃÁ¶ È¿°ú(ã·ðÓüùÍý)
  • glucose effect
    ±Û·çÄÚ½º È¿°ú(üùÍý)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • photoelectric effect
    ±¤ÀüÈ¿°ú
  • piezoelectric effect
    ¾ÐÀüÈ¿°ú
  • radiation effect
    ¹æ»ç¼±È¿°ú
  • radio-frequency thermal effect
    °íÁÖÆÄ¿­È¿°ú
  • reverse piezoelectric effect
    ¿ª¾ÐÀüÈ¿°ú
  • RF antennae effect
    °íÁ֯ľÈÅ׳ªÈ¿°ú
  • shielding effect
    Â÷ÆóÈ¿°ú
  • siphonage effect
    ½ÎÀÌÆùÈ¿°ú
  • spatial presaturation effect
    °ø°£ÀüÆ÷È­È¿°ú
  • spin phase effect
    ½ºÇÉÀ§»óÈ¿°ú
  • T1 shortening effect
    T1´ÜÃàÈ¿°ú
  • T2 shortening effect
    T2´ÜÃàÈ¿°ú
  • volume averaging effect
    ¿ëÀûÆò±ÕÈ­È¿°ú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
EAE Early Asthmatic Effect
LAE   1) Late Asthmatic Effect
  2) Left Atrial Enlargement
SE Side Effect
AE above-elbow [amputation]; acrodermatitis enteropathica; activation energy; adult erythrocyte; advers...
AEF allogenic effect factor; amyloid enhancing factor; aorto-enteric fistula
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
LOAEL Lowest Observed Adverse Effect Level
LOEL Lowest Observed Effect Level
LOEC Lowest observed effect concentrations
ME McCollough Effect
NOAEL No Observable Adverse Effect Level
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • clasp knife effect
    Á¢´Â Ä® È¿°ú
  • cytopathogenic effect
    ¼¼Æ÷ º¯¼º Çö»ó, ¼¼Æ÷ º´º¯ È¿°ú
  • Deelman`s effect
    µ¨¸¸ È¿°ú
  • detergent effect
    Á¤È­ ÀÛ¿ë
  • domino effect
    µµ¹Ì³ë È¿°ú
  • Donnan effect
    µµ³­ È¿°ú
  • Doppler effect
    µµÇ÷¯ È¿°ú, Doppler È¿°ú
    1. ±Ù¿øÁö¿¡ ´ëÇÑ ¼ö½ÅÁöÀÇ »ó´ëÀûÀÎ ¿îµ¿À¸·ÎºÎÅÍ ¾ß±âµÇ´Â Á֯ļöÀÇ ¸í¹éÇÑ º¯È­. 2. ¾î¶² ¹°Ã¼°¡ ¿îµ¿ »óÅ¿¡ ÀÖÀ» ¶§ ³ªÅ¸³ª´Â ¹ÝÇâµÇ´Â ¹æ»ç¼±¿¡¼­ Áøµ¿¼öÀÇ º¯È­´Â µµÇ÷¯ È¿°úÀÇ °á°úÀÌ´Ù. ¹æ»ç¼±ÀÇ ±Ù¿øÀ¸·ÎºÎÅÍ ¶³¾îÁø ¹°Ã¼ÀÇ ¿îµ¿Àº Á¤Áö »óÅÂÀÇ ¹°Ã¼¿¡ ºñ±³ÇØ º¼ ¶§ ´õ ³·Àº Áøµ¿¼öÀÇ ¹ÝÇâÀ» ÀÏÀ¸Å³ °ÍÀÌ´Ù. ¹æ»ç¼±ÀÇ ±Ù¿øÀ» ÇâÇÑ ¿îµ¿Àº ´õ ³ôÀº Áøµ¿¼ö¸¦ ÀÏÀ¸Å²´Ù.
  • dose rate effect
    ¼±·®À² È¿°ú
  • dose-effect relationship
    ¼±·® ¿µÇâ °ü°è
  • double effect
    ÀÌÁß È¿°ú
  • drug side effect
    ºÎÀÛ¿ë
  • efferent effect
    ¿ø½É È¿°ú
  • entry slice effect
    À¯ÀÔ ´Ü¸é È¿°ú
  • first pass effect
    ÀÏÂ÷ Åë°ú È¿°ú
  • focus effect
    ÃÐÁ¡ È¿°ú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
Mach effect The appearance of a light or dark line on a radiograph where there is a concave or convex interface in the subject, a physiological optical form of edge enhancement.
See: Mach's band.
(05 Mar 2000)
raman effect <radiobiology> A phenomenon observed in the scattering of light as it passes through a transparent medium, the light undergoes a change in frequency and a random alteration in phase due to a change in rotational or vibrational energy of the scattering molecules.
(09 Oct 1997)
gene dosage effect In codominant alleles, the more or less linear relationship between the phenotypic value and the number of genes of one type substituted by another type.
(05 Mar 2000)
generation effect Variation in health status arising from the different causal factors of disease to which each successive generation born is exposed as it passes through life.
(05 Mar 2000)
rebound effect The characteristic of a drug to produce reverse effects when either the effect of the drug has passed or when the patient no longer responds to the drug.
(18 Nov 1997)
Venturi effect Term applied to the operation of a Venturi tube and similar systems.
(05 Mar 2000)
mass effect <neurology> Damage to the brain due the bulk of a tumour, the blockage of fluid or excess accumulation of fluid within the skull.
(16 Dec 1997)
red drop effect Experimental observation that the photosynthetic efficiency of monochromatic light is greatly reduced above 680 nm, even though chlorophyll absorbs well up to 700 nm. Led to the discovery of the two light reactions of photosynthesis.
See: photosystems I and II.
(18 Nov 1997)
gibbs-donnan effect The observation that charged molecules starting on one side of a semipermeable membrane sometimes will not evenly distribute themselves by diffusion on both sides of the membrane. This effect is probably because there are other charged substances already present which cannot move through the membrane themselves and which are creating an electric field that influences the movement of the incoming charged molecules.
(09 Oct 1997)
maternal effect gene Gene, usually required for early embryonic development, whose product is secreted into the egg by the mother. The phenotype is thus determined by the mother's, rather than the egg's, genotype.
Compare:. Zygotic effect gene.
See: egg polarity gene.
(18 Nov 1997)
Pasteur effect <biochemistry> Decrease in the rate of carbohydrate breakdown that occurs in yeast and other cells when switched from anaerobic to aerobic conditions. Results from a relatively slow flux of material through the biochemical pathways of respiration compared with those of fermentation.
(18 Nov 1997)
Pasteur's effect The inhibition of fermentation by oxygen, first observed by Pasteur; either not observed, or only slightly observed, in malignant tumours.
Compare: Crabtree effect.
(05 Mar 2000)
glucose effect <biochemistry> The ability of the sugar glucose to block sugar metabolism by keeping the genes which make the enzymes involved in the early steps of sugar metabolism from making those enzymes.
(09 Oct 1997)
greenhouse effect The effect of certain gases in the Earth's atmosphere in trapping heat from the sun.
(05 Dec 1998)
Rivero-Carvallo effect Inspiratory increase in the systolic murmur of tricuspid insufficiency; the characteristic distinguishing tricuspid insufficiency from mitral insufficiency.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • tunnel effect
    ÅͳΠȿ°ú !
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á